Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 1996, Alta Partners is a healthcare venture capital firm located in the San Francisco Bay Area. The firm has raised a total of $2.8 billion across 12 funds and has a team of experienced partners who previously worked at Burr, Egan, Deleage & Co. Alta has contributed to the development of over 75 FDA-approved products, showcasing its strong track record in the healthcare sector.
Alta Partners invests in the healthcare and life sciences sectors, targeting early-stage opportunities from pre-seed to Series C. The firm emphasizes building small, focused portfolios to ensure high standards and dedicated support for each investment. They seek to partner with entrepreneurs tackling significant healthcare challenges through innovative technology and scientific advancements.
Notable portfolio companies include Allakos, Inc., a clinical-stage biotechnology company; DispatchHealth, a home-based care delivery platform; Vir Biotechnology, focused on infectious diseases; eGenesis, developing human-compatible organs; and Be Biopharma, which is pioneering B cells as medicines.
To pitch Alta Partners, email alta@altapartners.com with your deck for consideration.
Yes, Alta Partners often leads investment rounds, particularly in early-stage companies where they can provide significant support and guidance.
Alta Partners is open to follow-on investments, especially for companies that demonstrate strong growth and potential in their respective markets.
Alta Partners has a total fund size of $2.8 billion, raised across 12 funds since its inception.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.